Healthy Aging — INNOVATEDIGNITY: Co-designing Digital Health Technologies With Older People in Homecare Settings.
Citation(s)
Cecula P, Behan SD, Maruthappu M COVID-19: Challenges and opportunities in the care sector. EClinicalMedicine. 2020 May 11;23:100390. doi: 10.1016/j.eclinm.2020.100390. eCollection 2020 Jun.
Chiu, C -J.; Hu, Y.-H.; Lin, D.-C.; Chang, F.-Y.; Chang, C.-S.; Lai, C.-F. The attitudes, impact, and learning needs of older adults using apps on touchscreen mobile devices: Results from a pilot study. Computer Human Behaviour 2016, 63,189-197.
Dahlberg, K , Dahlberg, H., & Nyström, M. Reflective lifeworld research (2nd ed.). 2008 Lund: Studentlitteratur.
El Emam K Guide to the De-Identification of Personal Health Information. CRC Press, 2013.
European Commission (EC) Open Research Data and Data Management Plans. Brussels: ERC Scientific Council 2019. Available Online: https://erc.europa.eu/sites/default/files/document/file/ERC_info_document-Open_Research_Data_and_Data_Management_Plans.pdf
Hahn J Structure of a Dissertation for a Participatory Phenomenology Design. In: Strang K.D. (eds) The Palgrave Handbook of Research Design in Business and Management. 2015.Palgrave Macmillan, New York.
Lawton MP Competence, environmental press, and the adaptation of older people. In: Lawton MP, Windley PG, Byerts TO, editors. Aging and the environment: Theoretical approaches. New York: Springer. 1982.pp. 33-59.
National Institute for Health and Care Excellence Evidence standards framework for digital health technologies.2019. https://www.nice.org.uk/Media/Default/About/what-we-do/our-programmes/evidence-standards-framework/user-guide.pdf
Peek ST, Wouters EJ, Luijkx KG, Vrijhoef HJ What it Takes to Successfully Implement Technology for Aging in Place: Focus Groups With Stakeholders. J Med Internet Res. 2016 May 3;18(5):e98. doi: 10.2196/jmir.5253.
Raleigh VS Stalling life expectancy in the UK. BMJ. 2018 Sep 27;362:k4050. doi: 10.1136/bmj.k4050.
Ramos MC Some ethical implications of qualitative research. Res Nurs Health. 1989 Feb;12(1):57-63.
Renaud, K ; Karen, B.J. Judy Predicting technology acceptance and adoption by the elderly: A qualitative study. In Proceedings of the ACM International Conference Proceeding Series, Wilderness, South Africa, 6-8 October 2008; Volume 338.
Sanders, E B.-N., Generative Tools for CoDesigning in Scrivener, Ball and Woodcock, eds. Collaborative Design (London Limited: Springer-Verlag, 2000).
Scandurra I, Sjölinder M Participatory Design With Seniors: Design of Future Services and Iterative Refinements of Interactive eHealth Services for Old Citizens. Med 2 0. 2013 Oct 8;2(2):e12. doi: 10.2196/med20.2729. eCollection 2013 Jul-Dec.
Sleeswijk V F., Stappers, P.J., van der Lugt, R., and Sanders, E.B.N. Contextmapping: experiences from practice. CoDesign.2005. 1 (2), 119-149. DOI: 10.1080/15710880500135987
Stoecker R Three crucial turns on the road to an adequate understanding of human dignity. In Humiliation, degradation, dehumanization. 2011; pp. 7-17. Springer, Dordrecht.
United Nations Ageing. 2019.Retrieved September 28, 2020, from https://www.un.org/en/sections/issues-depth/ageing/
University of Brighton Brighton and Hove Digital Health Living Lab. 2018.Retrieved September 28, 2020, from https://www.brighton.ac.uk/research-and-enterprise/enterprise/enterprise-projects/brighton-and-hove-digital-health-living-lab.aspx
Usher KJ, Arthur D Process consent: a model for enhancing informed consent in mental health nursing. J Adv Nurs. 1998 Apr;27(4):692-7. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
